Medication info
Pitacuzet Tablets 1/10 mg (Pitavastatin Calcium Hydrate, Ezetimibe)

Pitacuzet Tablets 1/10 mg (Pitavastatin Calcium Hydrate, Ezetimibe)

Prescription medicationTabletOral
Ingredient · strength
Pitavastatin Calcium Hydrate›1.102mg / 1 tabletEzetimibe›10mg / 1 tablet
Manufacturer / importer
Ildong Pharmaceutical Co., Ltd.
Appearance
Pale green round film-coated tablet
Packaging
30 tablets per bottle
Approval status
Active

MFDS item code 202600265 · Approved 2026.01.29

Summary

Main use
Improvement of primary hypercholesterolemia and mixed dyslipidemia
Who takes it
Adults
Adult dose
Administer 1/10 mg once daily, regardless of meals. Patients must continue to follow a standard cholesterol-lowering diet before and during treatment with this medicine. Patients taking pitavastatin calcium and ezetimibe concomitantly may switch to this medicine (a combination product containing the same amount of each active ingredient) for convenience. Administration of this medicine (pitavastatin calcium/ezetimibe combination) is not recommended in patients with moderate hepatic impairment. Do not administer this medicine (pitavastatin calcium/ezetimibe combination) to patients with severe hepatic impairment.

Ingredients

Manufacturer
Ildong Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of primary hypercholesterolemia and mixed dyslipidemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed dyslipidemia
  • elevated total cholesterol
  • elevated LDL cholesterol
  • elevated Apo B protein
  • elevated triglycerides
  • elevated non-HDL cholesterol
View approved original text

This medication helps lower high total cholesterol, LDL cholesterol, Apo B protein, triglyceride, and non-HDL cholesterol levels in patients with primary hypercholesterolemia and mixed dyslipidemia, while increasing HDL cholesterol levels. It is mainly used in combination with dietary therapy to improve blood lipid levels, thereby reducing the risk of cardiovascular diseases. This drug is particularly suitable for patients with heterozygous familial and non-familial primary hypercholesterolemia. It is used to improve health status by controlling blood lipid concentrations through safe and effective treatment.

How to take

Adult dose

Administer 1/10 mg once daily, regardless of meals. Patients must continue to follow a standard cholesterol-lowering diet before and during treatment with this medicine. Patients taking pitavastatin calcium and ezetimibe concomitantly may switch to this medicine (a combination product containing the same amount of each active ingredient) for convenience. Administration of this medicine (pitavastatin calcium/ezetimibe combination) is not recommended in patients with moderate hepatic impairment. Do not administer this medicine (pitavastatin calcium/ezetimibe combination) to patients with severe hepatic impairment.

Precautions

This drug should not be used in certain patients. For example, patients with allergic reactions to this medication or a history of such experiences, patients with active liver disease or persistently elevated liver enzyme levels, patients with severe liver dysfunction, and those taking cyclosporine should not be treated with this medication. Additionally, patients with myopathy, women who are pregnant or may become pregnant, nursing mothers, and children should not be administered this drug as there is no experience of use. This drug contains lactose and should not be taken by patients with lactose intolerance or related genetic diseases. This drug should be used with caution in patients with slightly reduced liver function, those who consume excessive alcohol, patients with renal dysfunction, hypothyroid patients, patients with genetic muscle diseases, or the elderly. In particular, when taken with fibrate drugs or niacin, there is an increased risk of muscle damage and renal dysfunction, so caution is necessary. During treatment with this drug, side effects such as muscle pain, weakness, abdominal pain, skin rash, itching, and abnormal liver function may occur, and patients should consult a doctor immediately if these symptoms occur. Regular liver function tests and muscle-related tests should be performed, and treatment may be discontinued if abnormal findings are detected. This medication is not to be administered to pregnant or nursing women, and women who may become pregnant should consult a doctor before taking it. Safety and efficacy in children have not been confirmed, so it is not used. No special dosage adjustments are needed for the elderly; however, they should use the drug with caution due to the higher likelihood of adverse reactions. This drug may interact with other medications, so especially when taken with cyclosporine, fibrate drugs, niacin, or erythromycin, prescribing should follow a physician's advice, as concurrent use may increase the risk of muscle damage. In cases of overdose, there is no specific antidote, so appropriate treatment and supportive therapy should be provided based on symptoms, and liver function and muscle enzyme levels should be monitored periodically. Finally, this drug should be stored out of reach of children and not transferred to another container.

Side effects

Soreness, rash, abdominal pain, chest pain, muscle pain, subjective symptoms adverse reactions (abdominal pain, rash, fatigue, paralysis, itching), increased γ-GT, elevated plasma creatine phosphokinase levels, increased serum ALT, increased serum AST, headache, muscle pain, weakness, jaundice, thrombocytopenia, hives, erythema, angioedema, elevated bilirubin, increased cholinesterase, stiffness, drowsiness, insomnia, heaviness in the head, dizziness, thirst, indigestion, abdominal bloating, constipation, stomatitis, vomiting, loss of appetite, glossitis, nausea, gastrointestinal discomfort, diarrhea, hypersensitivity, headache, dizziness, skin tingling, insomnia, sleep disorders, loss of appetite, elevated blood pressure, chest discomfort, weakness, itching, palpitations, fatigue, skin pain, burning sensation, joint pain, edema, blurred vision, photophobia, hearing loss, hematuria, elevated uric acid levels, increased serum potassium and phosphate, taste disturbances, discolored urine, fatigue, positive antinuclear antibody, hair loss, sleep disorders, memory loss, depression, interstitial lung disease, sexual dysfunction, diabetes, immune-mediated necrotizing myopathy, severe muscle weakness, ocular myasthenia gravis, facial edema, arm edema, headache, diabetic neuropathy, tremors, upper abdominal pain, vomiting, gastritis, epigastric discomfort, belching, gastrointestinal disorder, gastroesophageal reflux disease, tongue disorders, hives, sweating, rash, upper respiratory infection, conjunctival hyperemia, renal failure, liver dysfunction, increased serum creatinine, elevated blood pressure, increased blood urea, increased CPK, abnormal liver function tests, anaphylaxis, erythema multiforme, pancreatitis, cholelithiasis, cholecystitis, skin and mucous membrane syndrome, toxic epidermal necrolysis, eosinophilia, systemic symptom-associated drug reactions, severe skin adverse reactions, drug-induced liver injury

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. The recommended storage temperature is at room temperature between 1 and 30 degrees Celsius. This helps maintain the drug's effectiveness over time.

Appearance and packaging

Appearance

Pale green round film-coated tablet

Package unit

30 tablets per bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.